Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 20, 2019

SELL
$125.07 - $143.67 $859,105 - $986,869
-6,869 Closed
0 $0
Q2 2019

Jul 29, 2019

BUY
$123.4 - $148.55 $847,634 - $1.02 Million
6,869 New
6,869 $975,000
Q1 2019

Apr 18, 2019

SELL
$104.82 - $146.73 $1.15 Million - $1.61 Million
-11,006 Closed
0 $0
Q4 2018

Jan 16, 2019

BUY
$105.09 - $137.23 $1.16 Million - $1.51 Million
11,006 New
11,006 $1.25 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.64B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Highland Capital Management, LLC Portfolio

Follow Highland Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management, LLC with notifications on news.